FacebookTwitterGoogle+RedditEmail

FDA Strips Critic of Voting Rights

It’s said that it takes 22 FDA safety officers to change a light bulb: 12 to defend the decision to install it, 8 to call it another “lighting option,” 6 to quote drug industry studies and one to say it doesn’t need changing, it just needs a better label. This week’s hearings into birth control pills Yaz, Yasmin, Beyaz and Safyral confirm the FDA’s dedication to pharmalateralism.

Bayer launched Yaz in 2006 as a pill that goes “beyond birth control” to treat acne and severe PMS, all the while avoiding the water retention of traditional birth control pills. But soon, previously healthy teenagers experienced “beyond birth control” effects they hadn’t expected. Fifteen-year-old Katie Ketner had her gallbladder removed after taking Yaz, Susan Gallenos had a stroke and part of her skull removed and Michelle Pfleger, 18, collapsed and died of a pulmonary thromboemboli, according to published reports.

The FDA could have held hearings into the safety of the Yaz ingredient, drospirenone, as early as 2002, instead of this week. That’s when the newsletter, Worst Pills Best Pills, warned that drospirenone, just approved in the pill Yasmin, “has never before been marketed in the US,” and could cause “serious heart and other health problems such as a change in acid balance of the blood and muscle weakness.”

But instead of investigating the drug nine years ago, the FDA decided to ban the newsletter’s editor, Sidney Wolfe, MD, head of the Public Citizen Health Research Group from voting at this week’s Yaz hearings, because the newsletter had termed the drug a “do not use.” The FDA accused Wolfe of an “intellectual conflict of interest.”

This is not the first time the FDA has silenced Wolfe. During 2010 hearings about Jazz Pharmaceuticals’ fibromyalgia drug Rekinla, Wolfe’s microphone was turned off when he asked why the manufacturer’s guilty plea and $20 million penalty for illegal marketing a different drug was never brought up at the hearings. Was it not relevant?

Jazz’s off-label marketing, “is a matter related to compliance and it’s not a matter that’s related to the topic under discussion today,” explained Bob Rappaport, MD, director of the FDA Division of Anesthesia & Analgesia Products. The only significance of bringing up the wrongdoing case would be to, “impugn the sponsor in the hopes that the committee would be punitive towards them in your deliberations and recommendations regarding this application,” said Rappaport. Why should a $20 million guilty plea affect future approvals?

Not only was the Jazz guilty plea irrelevant, the FDA did not even know about it before Wolfe’s disclosure said published reports.

Nor is this the first time the FDA’s right hand does not know what the FDA’s left hand is doing. Just three months before a major label change for the antipyschotic drug Seroquel, Janet Woodcock, MD, head of the Center for Drug Evaluation and Research told Project on Government Oversight a warning about mixing drugs would not happen.

“At this point, there is agreement within CDER that an interaction between quetiapine [Seroquel] and methadone that confers unreasonable risks to patients is exceedingly unlikely and, therefore, no further action is indicated regarding the labeling for these products or for related communication initiatives,” she writes in a rambling, defensive letter. But the ink was barely dry on the letter before the FDA announced that Seroquel “should be avoided” in combination with at least 12 other medicines including heart rhythm drugs, synthetic opioids like methadone, antibiotics, anti-infectives and other antipsychotics. Families’ of soldiers and others who died while taking Seroquel had said exactly that for years.

When a reporter asked about the apparent egg on the FDA’s face, Sandy Walsh, an FDA spokesperson, said Woodcock’s letter was still correct, “because the F.D.A. had found no biological basis for a problem or unusual numbers of deaths at normal dosages.” In other words, the deaths were just from drug interactions and overdoses. Whew.

Still the FDA’s claim that Wolfe (who received a personal phone call from Jayne Peterson of the FDA’s Advisors and Consultants Office informing him that his voting rights on Yaz had been suspended. The suspension decision was agreed upon by Dr Woodcock) has an “intellectual conflict of interest” reduces anyone who believes in consumer rights or governmental justice to the level of a six-digit pharma lobbyist. Holding an opinion, holding a lucrative pharma consultancy–same idea right?

In fact, FDA advisory committees are so packed with pharma consultants, its Psychopharmacologic Drugs Advisory Committee was actually chaired by a paid AstraZeneca speaker until 2009, even as it reviewed AstraZeneca drugs! The only reason AstraZeneca speaker Jorge Armenteros, MD was removed from voting and then his chairmanship was because the Philadelphia Inquirer exposed the extreme conflict of interest. The FDA would probably call the Inquirer’s reporting an “intellectual conflict of interest.

Martha Rosenberg’s first book, Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health, will be published by Prometheus Books next year.

More articles by:

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

Weekend Edition
August 17, 2018
Friday - Sunday
Daniel Wolff
The Aretha Dialogue
Nick Pemberton
Donald Trump and the Rise of Patriotism 
Joseph Natoli
First Amendment Rights and the Court of Popular Opinion
Andrew Levine
Midterms 2018: What’s There to Hope For?
Robert Hunziker
Hothouse Earth
Jeffrey St. Clair
Roaming Charges: Running Out of Fools
Ajamu Baraka
Opposing Bipartisan Warmongering is Defending Human Rights of the Poor and Working Class
Paul Street
Corporate Media: the Enemy of the People
David Macaray
Trump and the Sex Tape
CJ Hopkins
Where Have All the Nazis Gone?
Daniel Falcone
The Future of NATO: an Interview With Richard Falk
Cesar Chelala
The Historic Responsibility of the Catholic Church
Ron Jacobs
The Barbarism of US Immigration Policy
Kenneth Surin
In Shanghai
William Camacaro - Frederick B. Mills
The Military Option Against Venezuela in the “Year of the Americas”
Nancy Kurshan
The Whole World Was Watching: Chicago ’68, Revisited
Robert Fantina
Yemeni and Palestinian Children
Alexandra Isfahani-Hammond
Orcas and Other-Than-Human Grief
Shoshana Fine – Thomas Lindemann
Migrants Deaths: European Democracies and the Right to Not Protect?
Paul Edwards
Totally Irrusianal
Thomas Knapp
Murphy’s Law: Big Tech Must Serve as Censorship Subcontractors
Mark Ashwill
More Demons Unleashed After Fulbright University Vietnam Official Drops Rhetorical Bombshells
Ralph Nader
Going Fundamental Eludes Congressional Progressives
Hans-Armin Ohlmann
My Longest Day: How World War II Ended for My Family
Matthew Funke
The Nordic Countries Aren’t Socialist
Daniel Warner
Tiger Woods, Donald Trump and Crime and Punishment
Dave Lindorff
Mainstream Media Hypocrisy on Display
Jeff Cohen
Democrats Gather in Chicago: Elite Party or Party of the People?
Victor Grossman
Stand Up With New Hope in Germany?
Christopher Brauchli
A Family Affair
Jill Richardson
Profiting From Poison
Patrick Bobilin
Moving the Margins
Alison Barros
Dear White American
Celia Bottger
If Ireland Can Reject Fossil Fuels, Your Town Can Too
Ian Scott Horst
Less Voting, More Revolution
Peter Certo
Trump Snubbed McCain, Then the Media Snubbed the Rest of Us
Dan Ritzman
Drilling ANWR: One of Our Last Links to the Wild World is in Danger
Brandon Do
The World and Palestine, Palestine and the World
Chris Wright
An Updated and Improved Marxism
Daryan Rezazad
Iran and the Doomsday Machine
Patrick Bond
Africa’s Pioneering Marxist Political Economist, Samir Amin (1931-2018)
Louis Proyect
Memoir From the Underground
Binoy Kampmark
Meaningless Titles and Liveable Cities: Melbourne Loses to Vienna
Andrew Stewart
Blackkklansman: Spike Lee Delivers a Masterpiece
Elizabeth Lennard
Alan Chadwick in the Budding Grove: Story Summary for a Documentary Film
FacebookTwitterGoogle+RedditEmail